C-Jun NH2-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle

Yonsei Medical Journal

Volumn 52, Issue 3, 2011, Pages 420-428

  Ok, Seong Ho ^a   Jeong, Young Seok ^a   Kim, Jae Gak ^a   Lee, Seung Min ^a   Sung, Hui Jin ^a   Kim, Hye Jung ^b   Chang, Ki Churl ^b   Kwon, Seong Chun ^c   Sohn, Ju Tae ^b  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

2B adrenocep tors; Dexmedetomidine; Hypertension; Mitogen activated protein kinase; Rat aorta

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA 2B ADRENERGIC RECEPTOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ATIPAMEZOLE; DEXMEDETOMIDINE; IMIDAZOLE DERIVATIVE; LEVOMEDETOMIDINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NIFEDIPINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; ENZYME PHOSPHORYLATION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; RAT; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANTHRACENES; AORTA; DEXMEDETOMIDINE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79955639511     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.3.420     Document Type: Article

References (39)

1. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14.
2. Peltonen JM, Pihlavisto M, Scheinin M. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha 2-adrenoceptors. Eur J Pharmacol 1998;355:275-9.
3. Schmeling WT, Kampine JP, Roerig DL, Warltier DC. The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 1991;75:499-511.
4. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134-42.
5. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
6. Lawrence CJ, Prinzen FW, de Lange S. Hemodynamic and coronary vascular effects of dexmedetomidine in the anesthetized goat. Acta Anaesthesiol Scand 1997;41:830-6.
7. Jalonen J, Halkola L, Kuttila K, Perttilä J, Rajalin A, Savunen T, et al. Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance. J cardiothorac Vasc Anesth 1995;9:519-24.
8. Flacke WE, Flacke JW, Bloor BC, McIntee DF, Sagan M. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth 1993;7:41-9.
9. Guimaräes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001;53:319-56.
10. Mizobe T. [Adrenergic receptor and knockout mouse: 2). Alpha adrenergic receptor knockout mouse]. Masui 2001;50:12-9.
11. Akata T. General anesthetics and vascular smooth muscle: direct actions of general anesthetics on cellular mechanisms regulating vascular tone. Anesthesiology 2007;106:365-91.
12. Abdel-Latif AA. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med (Maywood) 2001;226:153-63.
13. Khan TA, Bianchi C, Ruel M, Voisine P, Sellke FW. Mitogen-activated protein kinase pathways and cardiac surgery. J Thorac Cardiovasc Surg 2004;127:806-11.
14. Kim B, Kim J, Bae YM, Cho SI, Kwon SC, Jung JY, et al. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension 2004;43:1086-91.
15. Lee YR, Lee CK, Park HJ, Kim H, Kim J, Kim J, et al. C-Jun N-terminal kinase contributes to norepinephrine-induced contraction through phosphorylation of caldesmon in rat aortic smooth muscle. J Pharmacol Sci 2006;100:119-25.
16. Carter RW, Kanagy NL. Tyrosine kinases regulate intracellular calcium during alpha (2)-adrenergic contraction in rat aorta. Am J Physiol Heart Circ Physiol 2002;283:H1673-80.
17. Roberts RE. Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha (2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein. Br J Pharmacol 2001;133:859-66.
18. Choi YS, Jeong YS, Ok SH, Shin IW, Lee SH, Park JY, et al. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release. Anesth Analg 2010;110:341-9.
19. Sung HJ, Sohn JT, Park JY, Hwang EM, Baik JS, Ogawa K. Direct effect of ropivacaine involves lipoxygenase pathway activation in rat aortic smooth muscle. Can J Anaesth 2009;56:298-306.
20. Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, McGeer PL. Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J 2006;20:2000-8.
21. Park MK, Kang YJ, Lee HS, Kim HJ, Seo HG, Lee JH, et al. The obligatory role of COX-2 expression for induction of HO-1 in ischemic preconditioned rat brain. Biochem Biophys Res Commun 2008;377:1191-4.
22. Kwak KH. Emergence agitation/delirium: we still don't know. Korean J Anesthesiol 2010;59:73-4.
23. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation. Am J Physiol 1998;275:C1081-6.
24. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 1999;84:505-15.
25. Watts SW, Yang P, Banes AK, Baez M. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 2001;38:539-51.
26. Civantos Calzada B, Aleixandre de Artiñano A. Alpha-adrenoceptor subtypes. Pharmacol Res 2001;44:195-208.
27. Yildiz O, Ulusoy HB, Seyrek M, Gul H, Yildirim V. Dexmedetomidine produces dual alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist actions on human isolated internal mammary artery. J Cardiothorac Vasc Anesth 2007;21:696-700.
28. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007;408:297-315.
29. Molin JC, Bendhack LM. Clonidine induces rat aorta relaxation by nitric oxide-dependent and-independent mechanisms. Vascul Pharmacol 2004;42:1-6.
30. Hamasaki J, Tsuneyoshi I, Katai R, Hidaka T, Boyle WA, Kanmura Y. Dual alpha (2)-adrenergic agonist and alpha (1)-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries. Anesth Analg 2002;94:1434-40.
31. Motulsky HJ, Snavely MD, Hughes RJ, Insel PA. Interaction of verapamil and other calcium channel blockers with alpha 1-and alpha 2-adrenergic receptors. Circ Res 1983;52:226-31.
32. Kim HJ, Sohn JT, Jeong YS, Cho MS, Kim HJ, Chang KC, et al. Direct effect of dexmedetomidine on rat isolated aorta involves endothelial nitric oxide synthesis and activation of the lipoxygenase pathway. Clin Exp Pharmacol Physiol 2009;36:406-12.
33. Vanhoutte PM. Calcium-entry blockers, vascular smooth muscle and systemic hypertension. Am J Cardiol 1985;55:17B-23B.
34. Cussac D, Schaak S, Denis C, Paris H. alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation. J Biol Chem 2002;277:19882-8.
35. Shah S, Sangari T, Qasim M, Martin T. Severe hypertension and bradycardia after dexmedetomidine for radiology sedation in a patient with acute transverse myelitis. Paediatr Anaesth 2008;18:681-2.
36. Zub D, Berkenbosch JW, Tobias JD. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Paediatr Anaesth 2005;15:932-8.
37. Sakurai Y, Obata T, Odaka A, Terui K, Tamura M, Miyao H. Buccal administration of dexmedetomidine as a preanesthetic in children. J Anesth 2010;24:49-53.
38. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
39. Joshi MS, Ferguson TB Jr, Johnson FK, Johnson RA, Parthasarathy S, Lancaster JR Jr. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci U S A 2007;104:9982-7.